NCT00427206View on ClinicalTrials.gov

Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing

PHASE4CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Alcohol Related Disorders
Interventions
DRUG

acetaminophen (4g/day)

DRUG

placebo

Trial Locations (2)

80204

Denver CARES, Denver

M5S 2S1

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Denver Health and Hospital Authority

OTHER

NCT00427206 - Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing | Biotech Hunter | Biotech Hunter